Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
Author:
Massimo Breccia et al
Publication:
Annals of Hematology
Publisher:
Springer Nature
Copyright © 2018, Springer-Verlag GmbH Germany, part of Springer Nature